Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Gomez

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Urology Reports|July 13, 2010
The use of botulinum toxin a in idiopathic overactive bladder syndromeChristopher S Gomez, Prashanth Kanagarajah, Angelo Gousse
Current Urology Reports|September 7, 2011
Bladder dysfunction in patients with diabetesChristopher S Gomez, Prashanth Kanagarajah, Angelo E Gousse
Current Urology Reports|August 13, 2014
UTIs in patients with neurogenic bladderMona S Jahromi, Amanda Mure, Christopher S Gomez
Current Urology Reports|August 28, 2009
Medical management of stress urinary incontinence: is there a future?Daniel J Caruso, Christopher S Gomez, Angelo E Gousse
Neurourology and Urodynamics|April 28, 2020
Overactive bladder and urgency urinary incontinence in men undergoing artificial urinary sphincter placementMona S Jahromi, Kyrra Engle, Daniel Furlong, et al.
Female Pelvic Medicine & Reconstructive Surgery|March 29, 2012
Repeat intradetrusor injections of onabotulinum toxin a for refractory idiopathic overactive bladder patients: a single-center experienceAngelo E Gousse, Prashanth Kanagarajah, Rajinikanth Ayyathurai, et al.
The Journal of Urology|August 18, 2009
Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrenceChristopher S Gomez, Pablo Gomez, Judith Knapp, et al.
The Journal of Urology|July 4, 2006
Frequency of ureteroscope damage seen at a tertiary care centerRobert I Carey, Christopher S Gomez, Giuseppe Maurici, et al.
Cancer|June 28, 2012
C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancerTravis J Yates, Judith Knapp, Miguel Gosalbez, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Urology Reports|July 13, 2010
The use of botulinum toxin a in idiopathic overactive bladder syndromeChristopher S Gomez, Prashanth Kanagarajah, Angelo Gousse
Current Urology Reports|September 7, 2011
Bladder dysfunction in patients with diabetesChristopher S Gomez, Prashanth Kanagarajah, Angelo E Gousse
Current Urology Reports|August 13, 2014
UTIs in patients with neurogenic bladderMona S Jahromi, Amanda Mure, Christopher S Gomez
Current Urology Reports|August 28, 2009
Medical management of stress urinary incontinence: is there a future?Daniel J Caruso, Christopher S Gomez, Angelo E Gousse
Neurourology and Urodynamics|April 28, 2020
Overactive bladder and urgency urinary incontinence in men undergoing artificial urinary sphincter placementMona S Jahromi, Kyrra Engle, Daniel Furlong, et al.
Female Pelvic Medicine & Reconstructive Surgery|March 29, 2012
Repeat intradetrusor injections of onabotulinum toxin a for refractory idiopathic overactive bladder patients: a single-center experienceAngelo E Gousse, Prashanth Kanagarajah, Rajinikanth Ayyathurai, et al.
The Journal of Urology|August 18, 2009
Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrenceChristopher S Gomez, Pablo Gomez, Judith Knapp, et al.
The Journal of Urology|July 4, 2006
Frequency of ureteroscope damage seen at a tertiary care centerRobert I Carey, Christopher S Gomez, Giuseppe Maurici, et al.
Cancer|June 28, 2012
C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancerTravis J Yates, Judith Knapp, Miguel Gosalbez, et al.
Pageof 1